What risks are associated with enrollment and credentialing misrepresentations?

What risks are associated with enrollment and credentialing misrepresentations?

• A. Increased patient satisfaction.
• B. Potential false claims exposure, FCA liability, and disqualification from participation in Medicare programs.
• C. Automatic immunity from enforcement.
• D. No impact on participation status.

Answer: (B)

Enrollment and credentialing rely on accurate statements about licensure, privileges, board certification, and employment status. When those representations are inaccurate, the government can treat the misrepresentation as driving improper payments—meaning false claims are being made to Medicare or other federal programs. That opens the door to False Claims Act liability, which can include civil penalties and treble damages. Additionally, CMS and other payers can determine a provider is not eligible to participate, resulting in suspension or disqualification from Medicare and other federal health care programs. Beyond these enforcement actions, such misrepresentations can trigger exclusions by oversight agencies and disciplinary actions by licensing boards, further restricting practice. Options suggesting only increased satisfaction, automatic immunity, or no impact do not reflect the serious legal and programmatic consequences of misrepresentation.

Enrollment and credentialing rely on accurate statements about licensure, privileges, board certification, and employment status. When those representations are inaccurate, the government can treat the misrepresentation as driving improper payments—meaning false claims are being made to Medicare or other federal programs. That opens the door to False Claims Act liability, which can include civil penalties and treble damages. Additionally, CMS and other payers can determine a provider is not eligible to participate, resulting in suspension or disqualification from Medicare and other federal health care programs. Beyond these enforcement actions, such misrepresentations can trigger exclusions by oversight agencies and disciplinary actions by licensing boards, further restricting practice.

Options suggesting only increased satisfaction, automatic immunity, or no impact do not reflect the serious legal and programmatic consequences of misrepresentation.